Does Pennant Group Inc (PNTG) offer a good opportunity for investors?

With 0.22 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.24 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $26.68 whereas the lowest price it dropped to was $25.495. The 52-week range on PNTG shows that it touched its highest point at $37.13 and its lowest point at $14.77 during that stretch. It currently has a 1-year price target of $36.00. Beta for the stock currently stands at 1.92.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PNTG was up-trending over the past week, with a rise of 0.19%, but this was down by -11.20% over a month. Three-month performance dropped to -20.50% while six-month performance rose 8.14%. The stock gained 75.84% in the past year, while it has gained 0.19% so far this year. A look at the trailing 12-month EPS for PNTG yields 0.69 with Next year EPS estimates of 1.08. For the next quarter, that number is 0.24. This implies an EPS growth rate of 28.13% for this year and 15.22% for next year. EPS is expected to grow by 13.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -4.58%.

Float and Shares Shorts:

At present, 34.35 million PNTG shares are outstanding with a float of 32.99 million shares on hand for trading. On 2024-12-13, short shares totaled 0.72 million, which was 211.0 higher than short shares on 1731628800. In addition to Mr. John J. Gochnour as the firm’s President & COO, Ms. Lynette B. Walbom CPA serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 0.78586 of PNTG’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, PNTG reported revenue of $180688000.0 and operating income of $10798000.0. The EBITDA in the recently reported quarter was $12400000.0 and diluted EPS was $0.2.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PNTG since 5 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With PNTG analysts setting a high price target of 40.0 and a low target of 32.0, the average target price over the next 12 months is 36.0. Based on these targets, PNTG could surge 50.55% to reach the target high and rise by 20.44% to reach the target low. Reaching the average price target will result in a growth of 35.49% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.94531 being high and $0.92541 being low. For PNTG, this leads to a yearly average estimate of $0.93536.